 lymphocyt anti-htlv-i/ii-posit blood donor recipi transfus safeti studi group transfus safeti studi repositori serum specimen late blood donor antibodi human t-cell lymphotrop viru htlv time recipi addit htlv studi immunophenotyp analys peripher blood lymphocyt anti-htlv-posit recipi late signific chang healthi control evalu immunophenotyp donor signific elev absolut count t-cell natur killer popul helper/induc suppressor/induc subset chang t-cell activ marker long-term recent htlv infect t-cell immunophenotyp pattern infect htlv human immunodefici viru type decreas count